Rapid destruction of the nose and face (midline) was firstly described by McBride in 1897 \[[@CR1]\]. Macroscopically the lesions usually looked like necrotic granuloma and the patients showed aggressive and lethal course, therefore the term "lethal midline granuloma (LMG)" or "granuloma gangrenescens" were used for this condition. Later the term LMG is popularly used. It had became evident that the LMG is composed of three different types of histology, i.e. Wegener's granulomatosis (WG), polymorphic reticulosis (PR) or midline malignant reticulosis (MMR), and malignant lymphoma \[[@CR2], [@CR3]\]. These diseases could be histologically differentiated from each other by taking clinical findings into account. WG is usually characterized by generalized necrotizing vasculitis involving both arteries and veins and the presence of glomerulitis \[[@CR4]\]. Cancer and specific inflammation such as tuberculosis also cause a condition indistinguishable from LMG.

PR exhibits a polymorphous pattern of proliferation consisting of large atypical cells with mono- or multinucleus, small lymphocytes, plasma cells, benign-appearing macrophages, neutrophils and much less frequently eosinophils. PR had been considered as a variant of malignant lymphomas because the disease is frequently disseminated \[[@CR2]\]. The nature of proliferating cells in PR had been controversial. Once the disease was termed as nasal T-cell lymphoma because the proliferating cells showed a positive immunoreactivity for polyclonal antibodies against T-cells \[[@CR5], [@CR6]\]. However, monoclonal rerrangement of the T-cell receptor genes was seldomly found in cases with "nasal T-cell lymphoma" \[[@CR7]\]. Later Ng et al. \[[@CR8]\] reported that the tumor cells showed a positive immunoreactivity for natural killer (NK) cell marker CD56. Subsequently it was shown that proliferating cells in PR had large granular lymphocyte morphology \[[@CR9]\], which is a character of NK cells or cytotoxic T-lymphocytes. There have been accumulating evidences that PR is a neoplasm of activated NK cells \[[@CR10]--[@CR13]\]: the proliferating cells usually show CD2^+^ , CD56^+^ , CD3ε^+^, CD7^−^, CD16^−^, cytotoxic granule-associated proteins^+^ and do not exhibit rearrangement of T-cell receptor or immunoglobulin genes (Fig. [1](#Fig1){ref-type="fig"}). Meanwhile rearrangement of T-cell receptor genes was recorded in the rare cases of PR \[[@CR14], [@CR15]\]. Although the upper respiratory tract, especially nasal region, is the common site of presentation, NK/T-cell lymphoma of nasal type may present in diverse extranodal sites such as gastrointestinal tract, skin, testis, liver, and spleen \[[@CR16]\]. In the World Health Organization classification, NK/T-cell lymphoma encompasses the lymphomas involving nasal area and nonnasal area. Until present, there have been many review articles on the clinical, pathological, immunohistochemical, and immunogenetical aspects of NK/T-cell lymphomas involving upper respiratory tract. This review focuses on the epidemiology and molecular pathogenesis of nasal NK/T-cell lymphoma (NLTCL). Fig. 1HE. Polymorphous pattern of proliferation in the nasal cavity. Large cells show positive immunoreactivity with CD3ε, TIA-1, and CD56. ABC method, ×400

Association with Epstein--Barr virus (EBV) {#Sec1}
==========================================

The association between EBV and human malignancies, including endemic Burkitt's lymphoma, Hodgkin lymphoma and non-Hodgkin's lymphoma (NHL) of either B- or T-immunophenotypes, has been reported. Etiological role of EBV for development of NKTCL was firstly reported in 1990 \[[@CR17]\]. Subsequent study revealed the constant association of NKTCL with EBV in the world (Fig. [2](#Fig2){ref-type="fig"}) (Table [1](#Tab1){ref-type="table"}) \[[@CR18]--[@CR23]\]. Sino-nasal lymphomas are immunophenotypically classified into NK/T-(CD56^+^), T-, and B-cell type with distinctive clinical features \[[@CR24]\]. CD56 positivity, therefore NKTCL, was closely associated with EBV positivity among sino-nasal lymphomas \[[@CR22]\]. EBV could be subtyped based on the difference in sequence of EBNA2 region, i.e. type A and type B \[[@CR25]\]. Almost all of the NKTCL in Korea and Japan had type A EBV, which is identical with the previous literature reporting that most cases of EBV-associated malignancies of immunocompetent patients in Asia had type A EBV \[[@CR26]\]. Predominance of type A EBV was also found in NKTCL in Malaysia \[[@CR27]\], indicating the predominance of type A EBV in NKTCL in Asia. Several studies indicated the occurrence of type B EBV in lymphoma of immunocompromised patients \[[@CR28]\]. Borisch et al. \[[@CR29]\] reported that three of six cases of NKTCL in Switzerland had type B EBV, although no findings suggestive of immunodeficiency were found in these patients. These findings suggest a geographic difference in the distribution of EBV subtype in the NKTCL. Fig. 2In situ hybridization with EBER-1 probe reveals positive signals in the nucleus of proliferating cell Table 1EBV in nasal NK/T-cell lymphomaSourceCountryEBV positive rate (%)EBV subtypeExpression of latent\[[@CR18]\]^a^France7/7 (100)NA7/7 LMP+\[[@CR20]\]China21/21 (100)NA5/21 LMP-1+\[[@CR21]\]Japan11/12 (92)10/11 typeA8/12 LMP-1+\[[@CR22]\]Korea15/16 (94)15/15 typeA7/15 LMP-1+\[[@CR24]\]Indonesia18/20 (90)NANA*EBV* Epstein--Barr virus, *LMP* latent membrane protein, *NA* not available^a^Fresh tissue samples were used in the analyses

As shown in Table [1](#Tab1){ref-type="table"}, the proliferating cells in NKTCL frequently express latent membrane protein (LMP) as revealed by immunohistochemistry. Latent infection gene products of EBV, EBNA-2 and LMP-1, serve as target antigens for the elimination of EBV infected cells by host cytotoxic T-lymphocytes (CTL) \[[@CR30]\]. Shen et al. \[[@CR31]\] showed that NKTCL cells are able to provide target epitopes of EBV for CTL. In immunocompromised hosts, proliferating cells expressing EBNA-2 and LMP-1 can escape from immune surveillance by the host CTL, which might result in the development of malignant lymphomas \[[@CR32]\]. However, systemic immunosuppression is not noted in patients with NKTCL, thus suggesting an unknown underlying mechanism for escape of LMP-1-expressing tumor cells from the CTL. Several mechanisms such as downregulation of the immunogenic EBV nuclear antigens and preferential selection of the deletion genotype of LMP-1 was reported by Chiang et al. \[[@CR33], [@CR34]\] and expression of IL-10, an immunosuppressive cytokine, was reported by Shen et al. \[[@CR31]\]. The cells expressing viral antigens are eliminated primarily by CTL in a MHC-class-I-restricted manner \[[@CR35]\]. Two CTL-epitopes were identified in LMP-1 that are possibly pan A\*02-restricted \[[@CR36]\]. It is possible that NKTCL patients show lower frequencies of A\*02 allele compared with those in the normal population. Indeed high-resolution genetic typing revealed significantly lower frequency of HLA-A\*0201 in NKTCL than in normal population \[[@CR37]\]. These findings suggest that HLA-A\*0201-restricted CTL responses may function in vivo to suppress the development of NKTCL, or in other words, role of EBV for NKTCL development.

Genetical changes {#Sec2}
=================

Lymphoma arises from clonal expansion of lymphoid cells that are transformed by the accumulation of genetic lesions affecting oncogenes and tumor suppressor genes. In general, amount of samples from NKTCL lesions available for genetical analyses is small, and samples usually contain massive necrotic areas. Therefore information for genetical changes in NKTCL has been relatively limited until present.

Alterations of tumor suppressor genes and oncogenes {#Sec3}
---------------------------------------------------

Polymerase chain reaction (PCR)---single strand conformation polymorphism (SSCP) followed by direct sequence method was employed for analyses of gene alterations in NKTCL. The genes analyzed by this method were p53, k-ras, c-kit, and β-catenin on the NKTCL cases from Asian countries \[[@CR38]--[@CR42]\] and Mexico \[[@CR43]\]. p53 is a well-known tumor suppressor gene that causes cells with damaged DNA to arrest at the G1 phase of cell cycle or stimulating expression of the BAX gene, the protein that promotes apoptosis \[[@CR44]\]. In a wide variety of human cancers, p53 gene mutations have been detected mainly in exon 5 through 8 \[[@CR45]\]. K-RAS, c-KIT, and β-catenin genes are oncogenes. Greenblatt et al. \[[@CR46]\] identified 50 studies in which sequencing of the entire coding region of p53 had been reported. Of the 560 mutations reported in those papers, 87% were found in exons 5--8, and most of the others were in exon 4 (8%). In the studies for NKTCL in Asia, exons 4--8 or exons 5--8 were examined in one institute (Table [2](#Tab2){ref-type="table"}). The frequency of p53 mutations was various by district: high in Japan and Indonesia and low in Mexico, Korea, and Shenyang. Shenyang situates at north China, which is adjacent to the Korean peninsula, suggesting that environmental and genetical factors might generate the differences in frequency. Transitions (G:C to A:T) were the predominant pattern of mutations except for Mexico, in which number of cases with mutations was only five \[[@CR43]\], thus the data from Mexico seemed to be not conclusive. Predominance of transition mutations suggests that some "endogenous" mutagens act in lymphomagenesis. The transition pattern of p53 mutations is known to be more susceptible to spontaneous genetic instability than transversion. While genetic instability as revealed by widespread microsatellite instability was not found in the cases with NKTCL \[[@CR47]\]. Table 2p53 mutations in nasal NK/T-cell lymphomaNumber of casesExons examinedFrequency of mutations (%)Predominance of transition mutationAsiaJapan \[[@CR41]\]584--862%yesKorea \[[@CR41]\]424--831%yesChinaBeijing, Chengdu \[[@CR38]\]425--848%yesShenyang \[[@CR40]\]204--840%yesIndonesia \[[@CR42]\]274--863%yesMexico \[[@CR43]\]215--824%no

Quintanilla-Martinez et al. reported the association of p53 overexpression with poor prognosis, and p53 mutations with large cell morphology and advanced stage \[[@CR43], [@CR48]\]. However these findings were not confirmed by other studies. \[[@CR15], [@CR38]\]

The c-KIT proto-oncogene encodes a receptor tyrosine kinase, which is involved in normal hematopoiesis, gametogenesis, and melanogenesis via the c-kit receptor-ligand system. \[[@CR49]\]. Because the development of acute leukemia or malignant lymphoma was reported in transgenic mice expressing KIT \[[@CR8], [@CR14], [@CR50]\], NKTCL in Asian countries was examined for the c-kit gene mutations \[[@CR41]\]. Frequency of c-kit mutations was significantly higher in China (Beijing, Chengdu) (10 of 14 cases: 71.4%) \[[@CR39]\] than in Japan (9 of 58 cases: 15.5%) \[[@CR41]\], Korea (5 of 42 cases:11.9%) \[[@CR41]\], northeast China (Shenyang) (2 of 20 cases:10%) \[[@CR40]\], and Indonesia (3 of 27 cases :11.1%) \[[@CR42]\]. These findings suggest that location-specific differences in etiological factors cause specific mutations in c-kit gene.

*FAS* Gene Mutations {#Sec4}
--------------------

Fas (Apo-1/CD95) is a 45 kDa membrane protein belonging to the tumor necrosis factor receptor family, and mediates programmed cell death (apoptosis) through binding of FAS ligand (Fas L) \[[@CR51]\]. Fas consists of 325 amino acids with a single transmembrane domain, including signal peptide. The 80-amino acid portion in the cytoplasm, designated as a death signaling domain, is essential for the apoptotic signal transduction. *FAS* gene mutations were reported in about 10% cases with sporadic non-Hodgkin's lymphoma \[[@CR52]\]. NKTCL frequently co-express FAS and FAS ligand (Fas L), but the tumor cells seldom undergo apoptosis. Some mechanisms for resistance to FAS/FAS L - induced apoptosis might work in the development of NKTCL, thus *FAS* gene mutations could be one of the mechanisms. Two reports support this notion: NKTCL cells in 9 of 15 (60%) cases \[[@CR53]\] and 7 of 14 (50%) cases \[[@CR54]\] showed mutations of *FAS* gene. Mouse T-cell lymphoma cells transfected with mutated *FAS* genes were resistant to apoptosis (Fig. [3](#Fig3){ref-type="fig"}, Fig. [4](#Fig4){ref-type="fig"}) \[[@CR54]\], indicating the mutations to be loss of function mutation. These findings suggest that accumulation of lymphoid cells with *FAS* mutations provides a basis for the development of NKTCL. Fig. 3Summary of the *FAS* gene mutations found in patients with nasal NKTCL. *The shaded rectangles* at the COOH-terminus of the protein represents the small peptide added because of the frameshift in the gene encoding FAS.TM: transmembrane domain Fig. 4The mouse WR19L cell line expressing recombinant human FAS protein with (T1102C, A978G, 1095 ins A) or without (wild type) mutations were incubated with various concentrations of anti-FAS antibody at 37.0°C for 16 h. Clones expressing FAS receptor with any mutations (A978G, 1095 ins A, T1102C) were resistant to apoptosis induced by the anti-FAS antibody

Others {#Sec5}
------

Various cytogenetic alterations have been reported, of which deletions of 6q are the common \[[@CR55]\].

Epidemiological features {#Sec6}
========================

It had been reported that NKTCL seemed to be relatively common among non-Hodgkin's lymphoma in Hong Kong \[[@CR56]--[@CR58]\]: malignant lymphomas affecting nose and nasopharyngeal region constituted 7.2% of extranodal lymphomas \[[@CR56]\] and 45 of 70 cases with malignant lymphomas in the nose, nasopharynx, and larynx had PR morphology \[[@CR57]\]. This disease is occasionally encountered in the hospitals in Japan \[[@CR5], [@CR59], [@CR60]\]. When one of the authors (KA) visited the USA in 1987, he noticed that the disease was quite rare in the USA, but they had consultation cases from Peru. Because Japanese and a part of Peruvian belong to Mongolian ethnic group, it was postulated that the Mongolian group might be much more frequently affected by this disease. Then they started to examine the frequency of NKTCL in Japan, Korea (Seoul), and China (Shanghai) during the period from 1987 to 1993. The results are summarized in Table [3](#Tab3){ref-type="table"} \[[@CR61]--[@CR63]\], in which the frequency of each disease constituting LMG is shown as the frequency per 100,000 patients who visited the Ear--Nose--Throat (ENT) clinic in 37 university hospitals in Japan, Ryukyu University Hospital in Okinawa, Japan, Yonsei University Hospital in Seoul, and Shanghai Medical University Hospital. All of the histological sections were reviewed by one of the authors (KA). Frequency of PR ranged from 8 to 40.8. That in the Institute of Laryngology and Otology, London (1966--1987) was four, showing two to ten times higher frequencies of the PR in the east Asian countries \[[@CR61]\]. The disease is rare in the USA \[[@CR64]\] and Europe \[[@CR65]\]. The patients with NKTCL seem to be clustered also in Latin American countries and Indonesia \[[@CR66], [@CR67]\]. Information from other parts of the world such as Africa, the Middle and Near East, and Rusia is helpful to elucidate the etiology of this disease. Table 3Frequency of lethal midline granuloma in Japan, Korea (Seoul), and China (Shanghai)DiseaseNumber of patients (frequency per 100,000 ENT patients)Japan other than Okinawa (1965--1986)Okinawa (1973--1991)Seoul (1979--1989)Shanghai (1979--1990)Wegener's granulomatosis64(4)1(3)0(0)1(4)Polymorphic reticulosis114(8)9(27.4)56(40.8)73(9.8)Malignant lymphoma82(6)11(33.5)15(10.9)54(7.2)Others42(3)1(3)6(4.4)0(0)Total302(21)22(69.9)77(56)128(17)

At the late 1990s, otorhinolaryngologists in both Korea and Japan had the impression that the frequency of PR appeared to be decreasing. Then the changes in frequency of PR with time among cases from Seoul and 59 university hospitals in Japan were examined \[[@CR68]\]: the frequency rate of PR per 100,000 outpatients of ENT clinics in Seoul decreased from 40 to 20 between the periods of 1977--1989 and 1990--1996. However, there were no significant changes in Japan during the period studies.

Life-style and environmental factors {#Sec7}
------------------------------------

Epidemiological studies have revealed that the NKTCL occurs much more frequently in Asian countries than in Western countries and it is closely associated with EBV infection. There are differences in frequencies of p53 and c-kit gene mutations among patients with NKTCL in Japan, China, and Korea. Recently the first case of familial NKTCL affecting a father and one of his six children was reported \[[@CR69]\]. They used large amounts of pesticide in a green house. An increase in the risk of developing NHL among individuals exposed to pesticides was reported \[[@CR70], [@CR71]\]. In addition, a correlation of exposure to certain pesticides and organochlorines with increased titers of antibodies to EBV was reported \[[@CR72]\]. All these findings might suggest a causative role for some genetical, environmental and life style factors in the development of NKTCL. Therefore, the epidemiological study to elucidate whether socioenvironmental ambient factors contribute to the development of NKTCL was conducted as a collaborative study of Japan, Korea and China (Table [4](#Tab4){ref-type="table"}) \[[@CR73]\]. The odd ratio (OR) of NKTCL was 4.15 (95% confidence interval (CI), 1.74--9.37) for farmers, 2.81 (CI 1.49--5.29) for producers of crops, and 4.01 (CI 1.99--8.09) for pesticide users. The ORs for crop producers, who minimized their exposure to pesticides by using gloves and glasses, and sprinkling downwind at the time of pesticide use, were 3.30 (CI 1.28--8.54), 1.18 (CI 0.11--12.13), and 2.20 (CI 0.88--5.53), respectively, which were lower than those for producers who did not take these precautions. Exposures to pesticides and chemical solvents could be causative factors for NKTCL. Previous studies showed the increased risk of NHL in individuals using pesticides, especially phenoxyacetic acid-type herbicides \[[@CR74]\]. Association of pesticides with risk of developing *t*(14;18) positive-NHL, but not *t*(14;18) negative-NHL, was reported \[[@CR75]\]. Table 4Risk of nasal NK/T-cell lymphoma in relation to cultivation of crops and pesticide useOdds ration (OR)^a^Number of cases*N* = 88Number of controls*N* = 30595% CILowerUpperCultivation of cropsAt present2.8127361.495.29More than 5 years5.0824192.4710.43PesticidesUsers4.0123231.998.09Type of pesticideHerbicide3.1713161.367.38Insecticide3.4520211.677.13Fungicide6.051061.9818.46PrecautionsGloves used3.3010111.288.54Gloves not used4.7613121.9311.72Mask used5.4414102.2013.47Mask not used2.829131.087.37Glasses used1.18130.1112.13Glasses not used4.5222202.179.42Sprinkling downward attended2.209160.885.53Sprinkling downward not attended8.451473.0123.70*CI* confidence interval^a^Adjusted for age (\<40, 40--59, \>60), sex (male/female) and country (Japan, Korea and China)

Conclusions {#Sec8}
===========

Clinical course of patients with NKTCL is usually highly aggressive. Therefore clarification of risk factors for disease development is especially important to establish a strategy for disease prevention. Because EBV infection and pesticides could be risk factors for NKTCL, investigation on effects of pesticides for EBV activation is needed. Employment of the similar kind of the epidemiological study is desirable in other areas than East Asia. Patients with NKTCL cluster in Asia and Latin American countries, therefore some genetical factors might be involved in the disease development. Further studies including HLA antigen typing of patients is important to further clarify the mechanism for disease development.
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